印度HPV疫苗接种:关键评价。

ISRN obstetrics and gynecology Pub Date : 2014-03-11 eCollection Date: 2014-01-01 DOI:10.1155/2014/394595
Aruna Nigam, Pikee Saxena, Anita S Acharya, Archana Mishra, Swaraj Batra
{"title":"印度HPV疫苗接种:关键评价。","authors":"Aruna Nigam,&nbsp;Pikee Saxena,&nbsp;Anita S Acharya,&nbsp;Archana Mishra,&nbsp;Swaraj Batra","doi":"10.1155/2014/394595","DOIUrl":null,"url":null,"abstract":"<p><p>Cervical cancer is the third most common cancer in women worldwide. The role of human papilloma virus (HPV) in the genesis of cervical carcinoma is well documented. The HPV 16 and 18 are found to be most commonly associated with invasive cervical carcinoma. The advent of cervical carcinoma vaccine has advanced the hopes that eradication of cervical carcinoma might be possible in future. The scenario of prevention of cervical carcinoma is completely different in developed and developing countries. The implementation of the vaccination as a routine in India is still controversial. Here we have tried to critically analyse these issues in Indian context. However it is clear that cervical cancer vaccine is not an immediate panacea and cannot replace the cervical cancer screening which is mandatory in Indian context. </p>","PeriodicalId":73520,"journal":{"name":"ISRN obstetrics and gynecology","volume":"2014 ","pages":"394595"},"PeriodicalIF":0.0000,"publicationDate":"2014-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/394595","citationCount":"28","resultStr":"{\"title\":\"HPV Vaccination in India: Critical Appraisal.\",\"authors\":\"Aruna Nigam,&nbsp;Pikee Saxena,&nbsp;Anita S Acharya,&nbsp;Archana Mishra,&nbsp;Swaraj Batra\",\"doi\":\"10.1155/2014/394595\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cervical cancer is the third most common cancer in women worldwide. The role of human papilloma virus (HPV) in the genesis of cervical carcinoma is well documented. The HPV 16 and 18 are found to be most commonly associated with invasive cervical carcinoma. The advent of cervical carcinoma vaccine has advanced the hopes that eradication of cervical carcinoma might be possible in future. The scenario of prevention of cervical carcinoma is completely different in developed and developing countries. The implementation of the vaccination as a routine in India is still controversial. Here we have tried to critically analyse these issues in Indian context. However it is clear that cervical cancer vaccine is not an immediate panacea and cannot replace the cervical cancer screening which is mandatory in Indian context. </p>\",\"PeriodicalId\":73520,\"journal\":{\"name\":\"ISRN obstetrics and gynecology\",\"volume\":\"2014 \",\"pages\":\"394595\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2014/394595\",\"citationCount\":\"28\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ISRN obstetrics and gynecology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2014/394595\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2014/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN obstetrics and gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2014/394595","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 28

摘要

宫颈癌是世界上第三大最常见的女性癌症。人乳头瘤病毒(HPV)在宫颈癌发生中的作用是有据可查的。HPV 16和18被发现与浸润性宫颈癌最常见。宫颈癌疫苗的出现使人们对将来根除宫颈癌产生了希望。在发达国家和发展中国家,预防宫颈癌的情况完全不同。在印度,将疫苗接种作为一项常规措施仍存在争议。在这里,我们试图在印度的背景下批判性地分析这些问题。然而,宫颈癌疫苗显然不是立即的灵丹妙药,也不能取代在印度强制进行的宫颈癌筛查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
HPV Vaccination in India: Critical Appraisal.

Cervical cancer is the third most common cancer in women worldwide. The role of human papilloma virus (HPV) in the genesis of cervical carcinoma is well documented. The HPV 16 and 18 are found to be most commonly associated with invasive cervical carcinoma. The advent of cervical carcinoma vaccine has advanced the hopes that eradication of cervical carcinoma might be possible in future. The scenario of prevention of cervical carcinoma is completely different in developed and developing countries. The implementation of the vaccination as a routine in India is still controversial. Here we have tried to critically analyse these issues in Indian context. However it is clear that cervical cancer vaccine is not an immediate panacea and cannot replace the cervical cancer screening which is mandatory in Indian context.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信